WO2018070956A2 - Wound and burn material with herbal agent - Google Patents
Wound and burn material with herbal agent Download PDFInfo
- Publication number
- WO2018070956A2 WO2018070956A2 PCT/TR2017/050373 TR2017050373W WO2018070956A2 WO 2018070956 A2 WO2018070956 A2 WO 2018070956A2 TR 2017050373 W TR2017050373 W TR 2017050373W WO 2018070956 A2 WO2018070956 A2 WO 2018070956A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- gelatin
- solution
- burn material
- tannic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Definitions
- the invention relates to a wound and burn material which is intended to be used in healthcare field, promotes healing of acute and chronic wounds and contains a bioabsorbable herbal agent with clotting effect, and to a method for production of the mentioned material.
- the invention relates to a gelatin (hydrocolloid polymeric matrix) based wound-burn material comprising cinnamon extract, which is obtained from dried barks of Cinnamomum verum tree and has collagen synthesis triggering function, crosslinking agent and clotting tannic acid, and a method for its production.
- cinnamon extract which is obtained from dried barks of Cinnamomum verum tree and has collagen synthesis triggering function, crosslinking agent and clotting tannic acid, and a method for its production.
- Grafts which are another example of wound dressing materials, are particularly preferred in burn and acute laceration related tissue losses.
- the mentioned material is not preferred since surgical intervention is required in the treatment, for which the mentioned material is used, and a matched donor is required.
- the transplant tissue may also be damaged, immune reactions due to the graft and related infections can be seen in the patient.
- Primary treatment step in acute lacerations is stopping the bleeding and starting the healing phase by achieving a strong clotting.
- Existing products are only aimed towards achieving the clotting and commercially available in liquid form sprays, powder form structures and various medication forms such as fibrin adhesives. While these products have no wound healing function, they cannot be used in treatment of chronic open wounds.
- a Brief Description of the Invention Present invention relates to a wound and burn material with a herbal agent which meets the aforementioned requirements, overcomes all disadvantages and provides some further advantages.
- Primary purpose of the invention is to produce an effective and combination wound and burn material for rapidly providing tissue integrity in acute and chronic wounds.
- a further purpose of the invention is to develop a wound material comprising a tree bark (cinnamon) extract which promotes regeneration by triggering collagen synthesis in both layers, to overcome the slow regeneration which is the most important problem encountered during wound healing.
- Most of the wound dressings comprise growth factors to increase regeneration. On the other hand, these growth factors increase cancer risk while prompting regeneration.
- the mentioned tree bark (cinnamon) extract provides a substantial increase in regeneration by supporting the cell activity, when applied in a gelatin matrix. Employing the regenerative and antimicrobial features of this extract in a biomaterial is the innovative aspect of the invention.
- a further purpose of the invention is develop a wound healing biomaterial comprising a tree bark (cinnamon) which contributes to the synthesis of intermediate molecules required in various stages of cell activities (cell growth, aging, differentiation, multiplication, combination, migration and programmed cell death). Furthermore, there are scientific studies which report the related wound healing biomaterial to contribute in reducing the cellular stress and preventing the spread of cancer cells.
- Cinnamon extract of the invention contributes to the restoration of the wound cosmetically by reducing scar tissue formation due to degeneration of the skin elasticity and lack of humidity, and this also supports the rehabilitation process in psychological aspects.
- a further purpose of the invention is to develop a wound-burn material, intended to be used also with acute wounds, which comprises "tannic acid”, which is also known as “tannin”, which is available in plants and used in medicine since old times for its vascular and mucosa contracting (clotting mechanism) effect.
- a further purpose of the invention is to develop a three dimensional and porous wound healing biomaterial by using a herbal crosslinking (genipin) agent, without causing high toxicity side effects.
- a further purpose of the invention is to provide a more effective wound-burn material production process, without causing temperature sensitive repairing and regenerative molecules to be denaturized, by employing a freeze drying process.
- a further purpose of the invention is to develop a fully bioabsorbable wound-burn material, which comprises 2 layers, includes key features required in critical steps of wound healing and having a synergic effect at the same time.
- Cinnamon extract obtained from dried barks of Cinnamomum verum tree, promotes synthesis of proteins such as collagen and elastin by stimulating fibroblast cells, which are main skin cells. Therefore it supports scabbing of the open wound while at the same time being incorporated in the cell membrane structure. Cinnamon extract, with its antibacterial and antifungal features, kills bacteria, helps preventing growth of resistant fungi and therefore development of infection is prevented. Cinnamon extract is rich in iron and calcium; and it is effective in clotting and enhancing the immune system. In addition to the abovementioned features, its usage in wound-burn treatment provides an important innovation to the technical field since it is an affordable plant extract.
- the other active agent used in the composition provided in the invention is tannic acid. Tannic acid supports the clotting mechanism by contracting the blood vessels and reducing the blood flow with its (anti-vasodilator) effect. It is antimicrobial and functions to protect the wound against infections. In addition, its antioxidant and antimutagenic features are also among the most important properties of tannic acid. Therefore it is advantageous in preventing chronic wounds becoming cancerous.
- genipin In the wound and burn material with herbal agent, genipin is used as a crosslinking agent. Genipin, which has much lower cytotoxicity compared to other crosslinking agents such as gluteraldehide, is more advantageous compared to glutarealdehide since it shows longer lasting stability. Therefore it provides a more stable 3 dimensional structure and presents high biocompatibility.
- genipin, gluteraldehide or aldehyde derivatives can be used as the relevant crosslinking agent.
- Gelatin hydrocolloid polymeric matrix
- It is another raw material that is present in the composition of the woung and burn material with herbal agent. It is an essential matrix element used in various biomaterials, in chemistry, pharmaceutics and food industry.
- the mentioned gelatin can be of animal or plant origin. Its purpose of use in the invention is controlled transfer of the relevant active agents inside the tissue and providing a foam that acts as a framework to help the cells attach together. Since gelatin has a polypeptide form, it also contributes to wound healing by being absorbed by body.
- Table 1 shows the raw materials used in the wound and burn material with herbal agent and ratios of their amounts. Following the basic review of the production steps, it is disclosed clearly in reference to the detailed description without being limiting in any way.
- Wound and burn material production process basically involves the following steps:
- Cinnamomum verum tree barks Cinnamon
- alcohol extracts After powdering the obtained cinnamon by grinding, this cinnamon powder is added into alcohol with 1 /6 (w/v) ratio and shaken for 24 hours at 25 °C. This shaken mixture is distilled with filter paper and the remaining colorful liquid evaporated using an evaporator. At the end, total extract is obtained.
- a 5 g of the pharmaceutical gelatin in the powder form is added into 100 ml purified water. Gelatin is dissolved inside a magnetic stirrer for 20 minutes at 37 °C and 250 rpm and homogenized. Finally, a 5% (w/v) gelatin solution is obtained.
- a total of 6 g pure genipin dust is added into 100 ml purified water at room temperature an distributed homogenously by stirring at 250 rpm for 10 minutes. Solution is maintained between +2 °C - +12 °C until the time of use and a solution with 6% (w/v) concentration is obtained.
- tannic acid powder is added into only one of the solutions containing 50 ml gelatin and cinnamon extract and homogenously dissolved by stirring at 37 °C and 250 rpm for 10 minutes in a magnetic stirrer. Then the tannic acid concentration becomes 1 % (w/v).
- Solutions prepared inside 2 separate containers are, while still keeping them in separate containers, are stirred at room temperature and at 1400 rmp for 15 minutes until foam structures are obtained.
- the resulting material from the device is the final product which has a spongy form, is porous and has a 2 layer structure.
- the layered hydrocolloid polymer mentioned in the invention absorbs exudate, tannic acid in the first layer diffuses into the tissue. Depending on the condition of the exudate and at most in 12 hours, the first layer dissolves and the second layer comes into contact with the wound. Fibroblast cells are excited and collagen synthesis is triggered since both layers contain cinnamon extract, which supports cell proliferation, has a regulating effect on apoptosis mechanisms, prevents excessive drying of the wound and provides protection against infection with its antimicrobial quality. Therefore, the condition of the wound is improved into a healing phase and the wound heals quickly.
- the invention which achieves an improvement in the normal healing duration by 1 /4 as a result of the conducted studies, is suitable for use with both acute and chronic wound cases.
- the drying process mentioned in the invention is based on absorption of the water molecules, which are present in the frozen material, under high pressure. This process is one of the required intermediate steps that is necessary to achieve the spongy material provided by the invention.
- the aforementioned 3 dimensional porous structure provides the physical structure required for the cells to attach together and helps a controlled emission of the active agents to the area of the wound by acting as a framework.
- Wound and burn material with herbal agent is placed onto any kind of open wound without an infection or right after an acute injury with bleeding, on the surface where the skin integrity is damaged, in a manner where the tannic acid containing layer of the invention comes into contact first.
- layer that contains tannic acid will support the clotting process by contracting the blood vessels and reducing the blood flow, and later upon contact with the other active agent, tissue healing process will start.
- tissue healing process will start.
- the tannic acid containing layer will enable the cells to attach together by contracting the tissue to restore the tissue integrity and with the other components of the invention melting on the wound surface, a synergic effect will be observed.
- composition of the invention can be used in acute injuries where a clotting effect is required and any kind of wounds when a rapid tissue healing is expected and not infected wounds. At the same time, its bioabsorbability enables it to be absorbed entirely by the wound in at most 24 hours. After applying the wound and burn dressing to the wound, it turns into a gel form by mixing with the wound fluid and entirely covers the wound surface; and also by covering the open nerve endings, it shows pain relieving effect.
- a wound and burn material with liquid for which is obtained by placing a solution containing cinnamon extract, gelatin and tannic acid and another solution containing only gelatin and cinnamon extract into spray containers without mixing can be applied by spraying.
- tannic acid containing gelatin-cinnamon solution should be transferred to the first phase storage place of the spray bottle.
- Gelatin- cinnamon solution that does not contain tannic acid should be transferred to the second phase storage place of the spray bottle to be used without mixing with the other solution. In this way, foam production and crosslinking agent usage is not required.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1820503.9A GB2566630A (en) | 2016-08-11 | 2017-08-08 | Wound and burn material with herbal agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201611293 | 2016-08-11 | ||
TR2016/11293 | 2016-08-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018070956A2 true WO2018070956A2 (en) | 2018-04-19 |
WO2018070956A3 WO2018070956A3 (en) | 2018-06-14 |
Family
ID=61656323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2017/050373 WO2018070956A2 (en) | 2016-08-11 | 2017-08-08 | Wound and burn material with herbal agent |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2566630A (en) |
WO (1) | WO2018070956A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112587716B (en) * | 2020-12-21 | 2022-07-15 | 中国科学院宁波材料技术与工程研究所慈溪生物医学工程研究所 | Tissue adhesive and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8722854B2 (en) * | 2010-12-23 | 2014-05-13 | Medskin Solutions Dr. Suwelack Ag | Degradation-stabilised, biocompatible collagen matrices |
TR201309048A2 (en) * | 2013-07-25 | 2015-02-23 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | A dermal matrix and production method thereof having synergistic effects comprising microparticles which provides tissue repair |
-
2017
- 2017-08-08 WO PCT/TR2017/050373 patent/WO2018070956A2/en active Application Filing
- 2017-08-08 GB GB1820503.9A patent/GB2566630A/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
None |
Also Published As
Publication number | Publication date |
---|---|
WO2018070956A3 (en) | 2018-06-14 |
GB2566630A8 (en) | 2019-03-27 |
GB2566630A (en) | 2019-03-20 |
GB201820503D0 (en) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aljghami et al. | Emerging innovative wound dressings | |
US10653810B2 (en) | Ready to use biodegradable and biocompatible device and a method of preparation thereof | |
Boateng et al. | Advanced therapeutic dressings for effective wound healing—a review | |
Gaspar-Pintiliescu et al. | Natural composite dressings based on collagen, gelatin and plant bioactive compounds for wound healing: A review | |
CN101249274B (en) | Preparation of bletilla striata polyose water gelatin of promoting wound healing and uses thereof | |
US6855860B2 (en) | Composite dressings for the treatment of wounds | |
DE69433939T2 (en) | HEMOSTATIC PLASTER | |
ES2934158T3 (en) | Bioactive collagen biomaterials and methods for their manufacture | |
BRPI1106859A2 (en) | Degradation stabilized collagen arrays, biocompatible | |
CN106581736B (en) | Medical adhesive taking giant salamander body surface mucus as raw material and preparation method thereof | |
Chen et al. | Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties | |
US20110311632A1 (en) | Stable chitosan hemostatic external patch and methods of manufacture | |
JP7465011B2 (en) | Wound healing compositions containing metal-organic frameworks | |
Egozi et al. | Biodegradable soy wound dressings with controlled release of antibiotics: Results from a guinea pig burn model | |
WO2017101020A1 (en) | Modified dressing | |
WO2017030388A1 (en) | Composition for treating skin wounds | |
US20180303674A1 (en) | Skin-protective hydrogel wound dressing | |
WO2018070956A2 (en) | Wound and burn material with herbal agent | |
CN106075552B (en) | Medical hemostatic sponge and preparation method thereof | |
JP2005095331A (en) | Foamed body sheet containing fishskin dermal collagen and its use | |
EP3793589B1 (en) | Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation | |
JPS62246370A (en) | Wound covering material | |
RU2467767C1 (en) | Composition for wound treatment and products on its basis | |
KR20220150047A (en) | The adhesive multi-function clear wound dressing materials | |
KR20170088084A (en) | Use of sulglycotide for promoting skin-wound-healing, and composition for external application comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17851908 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 201820503 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20170808 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 20/05/2019) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17851908 Country of ref document: EP Kind code of ref document: A2 |